Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Sérgio Paulo de Magalhães Simões | M | - |
Treat U SA
 Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | 14 jaar |
| Antonio F. Cruz | M | 71 |
Treat U SA
Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | - |
| Paulo Jorge Barradas de Oliveira Rebelo | M | - |
Treat U SA
Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | - |
| Miguel Botto | M | - |
Treat U SA
Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Portugal | 4 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Vera Moura
- Persoonlijk netwerk
